Wall Street as a Matter of Life and Death
For New York City AIDS activist Bobby Tolbert, drug profiteering and tax dodging by financial elites is a violation of basic American values.
History Shows us we Don’t Need Billionaire Doctors to Make Medical Breakthroughs
Our tax codes incentivize medical entrepreneurs to go for gold while patients are left juggling what’s best for them versus what they can afford.
Rare Wins for Tax Fairness Spark New Life Into the Movement
Congress can only ignore the blatantly dishonest practice of offshore tax evasion for so long.
The Treasury Department Could Help Block Offshore Tax Havens
Big Pharma company Pfizer is currently evading $40 billion in tax obligations and trying to make that permanent through a tax-dodging marriage with Irish firm Allergen.
The Cocktail Option to Curing Cancer
Congress should open the pathways for doctors and patients to participate in more innovative treatments.
Cash Rules Everything Around Martin
Pharma Bro’s one-of-a-kind album purchase exemplifies how the ultra rich are polluting our culture.
Will Congress Be Duped Again on Offshore Taxes?
While the rest of us pay the sticker price, lawmakers are considering a special deluxe tax rate for giant corporations.
Film: Fire In The Blood
IPS’ Global Economy and Foreign Policy In Focus projects co-sponsor this a shocking exposé of how pharmaceutical companies use patent law to keep profits unconscionably high even at the expense of peoples’ lives.
What Medical Mistakes?
Privilege rules at U.S. hospitals and patients are at the mercy of powerful players who operate with impunity.
The Ugly Business of Lethal Injection
Attorneys trying to prevent the cruelty of a botched execution are challenging states’ efforts to conduct experiments on their clients with new execution drugs.
Too Many Rulings are Supremely Courteous to Corporations
The Walmart case is only one example of the Supreme Court’s growing tendency to side with the interests of big corporations over the rights of ordinary citizens.
WikiLeaks XVII: Nigerian Extortion Butts Up Against Pfizer Blackmail
A Pfizer settlement in a Nigerian lawsuit turns ugly.